Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 15 Issue 4

TABLE OF CONTENTS Volume 15, Issue 4 (December 2012) In this issue Editorial Reviews Original Articles Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement 98 days from submission to publication* Scientific Reports is an open access journal publishing technically sound research across all areas of the natural sciences. Submit your next research to Scientific Reports *mean time for papers published in September 2012   Editorial Top Editor's Comments S J Freedland Editor Prostate Cancer Prostatic Dis 2012 15: 313; 10.1038/pcan.2012.43 Full Text Reviews Top MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics A Gordanpour, R K Nam, L Sugar and A Seth Prostate Cancer Prostatic Dis 2012 15: 314-319; advance online publication, February 14, 2012; 10.1038/pcan.2012.3 Abstract | Full Text Growth/differentiation factor-15: prostate cancer suppressor or promoter? P Vaňhara, A Hampl, A Kozubík and K Souček Prostate Cancer Prostatic Dis 2012 15: 320-328; advance online publication, February 28, 2012; 10.1038/pcan.2012.6 Abstract | Full Text AST-induced bone loss in men with prostate cancer: exercise as a potential countermeasure K A Bolam, D A Galvão, N Spry, R U Newton and D R Taaffe Prostate Cancer Prostatic Dis 2012 15: 329-338; advance online publication, June 26, 2012; 10.1038/pcan.2012.22 Abstract | Full Text Original Articles Top Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer Y Fukuma, H Matsui, H Koike, Y Sekine, I Shechter, N Ohtake, S Nakata, K Ito and K Suzuki Prostate Cancer Prostatic Dis 2012 15: 339-345; advance online publication, May 1, 2012; 10.1038/pcan.2012.14 Abstract | Full Text Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer A J Colquhoun, N A Venier, A D Vandersluis, R Besla, L M Sugar, A Kiss, N E Fleshner, M Pollak, L H Klotz and V Venkateswaran Prostate Cancer Prostatic Dis 2012 15: 346-352; advance online publication, May 22, 2012; 10.1038/pcan.2012.16 Abstract | Full Text Variants in the HEPSIN gene are associated with susceptibility to prostate cancer H J Kim, J H Han, I H Chang, W Kim and S C Myung Prostate Cancer Prostatic Dis 2012 15: 353-358; advance online publication, June 5, 2012; 10.1038/pcan.2012.17 Abstract | Full Text Identification of genetic risk associated with prostate cancer using ancestry informative markers L J Ricks-Santi, V Apprey, T Mason, B Wilson, M Abbas, W Hernandez, S Hooker, M Doura, G Bonney, G Dunston, R Kittles and C Ahaghotu Prostate Cancer Prostatic Dis 2012 15: 359-364; advance online publication, July 17, 2012; 10.1038/pcan.2012.19 Abstract | Full Text Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations C K M Ho, L Halley, J Wei and F K Habib Prostate Cancer Prostatic Dis 2012 15: 365-368; advance online publication, June 26, 2012; 10.1038/pcan.2012.24 Abstract | Full Text Transcriptional repression of RUNX2 is associated with aggressive clinicopathological outcomes, whereas nuclear location of the protein is related to metastasis in prostate cancer S J Yun, H-Y Yoon, S-C Bae, O-J Lee, Y-H Choi, S-K Moon, I Y Kim and W-J Kim Prostate Cancer Prostatic Dis 2012 15: 369-373; advance online publication, August 14, 2012; 10.1038/pcan.2012.31 Abstract | Full Text Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram A Kutikov, M R Cooperberg, A T Paciorek, R G Uzzo, P R Carroll and S A Boorjian Prostate Cancer Prostatic Dis 2012 15: 374-379; advance online publication, June 19, 2012; 10.1038/pcan.2012.21 Abstract | Full Text Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective? S B Stewart, C D Scales, Jr, J W Moul and S D Reed Prostate Cancer Prostatic Dis 2012 15: 380-385; advance online publication, July 10, 2012; 10.1038/pcan.2012.26 Abstract | Full Text Low serum neutrophil count predicts a positive prostate biopsy K Fujita, R Imamura, G Tanigawa, M Nakagawa, T Hayashi, N Kishimoto, M Hosomi and S Yamaguchi Prostate Cancer Prostatic Dis 2012 15: 386-390; advance online publication, July 10, 2012; 10.1038/pcan.2012.27 Abstract | Full Text The impact of county-level radiation oncologist density on prostate cancer mortality in the United States S Aneja and J B Yu Prostate Cancer Prostatic Dis 2012 15: 391-396; advance online publication, July 24, 2012; 10.1038/pcan.2012.28 Abstract | Full Text Safety and effectiveness of neoadjuvant luteinizing hormone-releasing hormone agonist plus low-dose estramustine phosphate in high-risk prostate cancer: a prospective single-arm study T Koie, C Ohyama, H Yamamoto, S Hatakeyama, T Yoneyama, Y Hashimoto and N Kamimura Prostate Cancer Prostatic Dis 2012 15: 397-401; advance online publication, August 14, 2012; 10.1038/pcan.2012.29 Abstract | Full Text Corrigendum Top The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study C Chong, L Fong, R Lai, W K O Lau, M Hartmann and S E Chia Prostate Cancer Prostatic Dis 2012 15: 402; advance online publication, August 28, 2012; 10.1038/pcan.2012.35 Full Text Advertisement Why submit your paper to Prostate Cancer and Prostatic Diseases? Over 90,000 recipients will receive via e-mail a copy of the table of contents for the issue in which your article is published. There are an average of 30,000 page views across the Prostate Cancer and Prostatic Diseases web site per month. On average authors receive a first decision on their paper within 30 working days. Visit our Author page to learn about the benefits of publishing in the Journal and guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.